Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States

Go back to Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States
(NYSE: BHVN) Delayed: 14.98 -0.71 (4.53%)
Previous Close $15.69    52 Week High
Open $14.91    52 Week Low
Day High $15.80    P/E N/A 
Day Low $14.33    EPS
Volume 1,509,785       

Pfizer Inc. (NYSE: PFE) Delayed: 28.00 -0.45 (1.58%)
Previous Close $28.45    52 Week High $37.39 
Open $28.02    52 Week Low $28.25 
Day High $28.15    P/E 16.97 
Day Low $27.72    EPS $1.65 
Volume 14,635,657       

(NASDAQ: PRTG) Delayed: 6.81 --0 (-0%)
Previous Close $6.81    52 Week High
Open $6.81    52 Week Low
Day High $6.81    P/E N/A 
Day Low $6.81    EPS
Volume 327,471